<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>MALDI-TOF-MS for rapid detection of staphylococcal Panton-Valentine leukocidin</dc:title>
  <dc:creator>Bittar, F.</dc:creator>
  <dc:creator>Ouchenane, Z.</dc:creator>
  <dc:creator>Smati, F.</dc:creator>
  <dc:creator>/Raoult, Didier</dc:creator>
  <dc:creator>Rolain, J. M.</dc:creator>
  <dc:subject>Staphylococcus aureus</dc:subject>
  <dc:subject>Panton-Valentine leukocidin</dc:subject>
  <dc:subject>Mass spectrometry</dc:subject>
  <dc:subject>Toxin production</dc:subject>
  <dc:subject>Virulence factor</dc:subject>
  <dc:description>Toxin-producing Gram-positive bacteria are responsible for emerging and life-threatening infections in humans worldwide. Both rapid toxin detection and adapted therapy are essential to limit the morbidity due to such toxins, especially staphylococcal Panton-Valentine leukocidin (PVL). Here we describe the use of a mass spectrometry profile generated by matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) followed by ClinProTools (TM) 2.0 software analysis to find a reproducible model able to identify PVL in Staphylococcus aureus strains. Eighty-one S. aureus strains were used and tested for the presence of PVL, toxic shock syndrome toxin (TSST-1) and mecA genes. The peak at 4448 mass-to-charge ratio (m/z) was the most relevant peak to differentiate between PVL-producing and non-PVL-producing S. aureus. A model using only this peak had an overall recognition capability of 100% and an overall cross-validation of 77.07%. Prospective evaluation of the model allowed two cases of PVL-producing strains to be detected within a few minutes during the time of care and before polymerase chain reaction (PCR) results. Our study represents a proof of concept for the use of such rapid technology as a point-of-care method to identify potential lethal toxin quickly. We believe that such a rapid method will be timely to help change the therapeutic strategy and could be used in the future for other pathogens and infectious diseases.</dc:description>
  <dc:date>2009</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010048268</dc:identifier>
  <dc:identifier>fdi:010048268</dc:identifier>
  <dc:identifier>Bittar F., Ouchenane Z., Smati F., Raoult Didier, Rolain J. M.. MALDI-TOF-MS for rapid detection of staphylococcal Panton-Valentine leukocidin. 2009, 34 (5),  467-470</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
